Dados B3 › Watcher
Watcher for EEEL3: events of CPFL TRANSMISSÃO S.A.
39 event(s) recorded for EEEL3, newest first. Each is a fact with both numbers and the filing that revealed it.
Type: all · Profit or loss · Net margin changed band · Net debt/EBITDA changed band · Restated financial statements · Confidence flag changed colour
| Public on | Type | Fact |
|---|---|---|
| 2025-11-13 | Net margin changed band | Net margin went from 12.3% in 2Q2025 to 15.5% in 3Q2025.ITR 3T2025, recebida pela CVM em 13/11/2025 |
| 2025-08-14 | Net margin changed band | Net margin went from 32.1% in 1Q2025 to 12.3% in 2Q2025.ITR 2T2025, recebida pela CVM em 14/08/2025 |
| 2023-03-16 | Net margin changed band | Net margin went from 6.0% in 2021 to 64.3% in 2022.DFP 2022, recebida pela CVM em 16/03/2023 |
| 2022-03-17 | Net margin changed band | Net margin went from 20.8% in 2020 to 6.0% in 2021.DFP 2021, recebida pela CVM em 17/03/2022 |
| 2017-04-03 | Net margin changed band | Net margin went from 12.8% in 2015 to 47.2% in 2016.DFP 2016, recebida pela CVM em 03/04/2017 |
| 2012-05-18 | Net margin changed band | Net margin went from 8.5% in 3Q2011 to 46.7% in 1Q2012.ITR 1T2012, recebida pela CVM em 18/05/2012 |
| 2012-04-13 | Net margin changed band | Net margin went from 19.1% in 2010 to 11.6% in 2011.DFP 2011, recebida pela CVM em 13/04/2012 |
| 2011-08-12 | Net margin changed band | Net margin went from 19.5% in 1Q2011 to 9.9% in 2Q2011.ITR 2T2011, recebida pela CVM em 12/08/2011 |
EEEL3 — company page · all events · JSON · how the watcher works. Descriptive, not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 14:45 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 14:45 UTC. If this does not match /saude, you are reading a cached copy.